Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial

• Joshua Kimani ,

  * E-mail: Jkimani@csrtkenya.org

  Affiliation College of Health Sciences, University of Nairobi, Nairobi, Kenya

  ⨯
• Kamija Phiri,

  Affiliation College of Medicine, University of Malawi, Blantyre, Malawi

  ⨯
• Steve Kamiza,

  Affiliation College of Medicine, University of Malawi, Blantyre, Malawi

  ⨯
• Stephan Duparc,

  Affiliation Medicines for Malaria Venture, Geneva, Switzerland

  ⨯
• Ayman Ayoub,

  Affiliation Pfizer Inc., Sandwich, Kent, United Kingdom

  ⨯
• Ricardo Rojo,

  Affiliation Pfizer Inc., Groton, CT, United States of America

  ⨯
• Jeffery Robbins,

  Affiliation Pfizer Inc., Groton, CT, United States of America

  ⨯
• Russell Orrico,

  Affiliation Pfizer Inc., Collegeville, PA, United States of America

  ⨯
• Pol Vandenbroucke

  Affiliation Pfizer Inc., New York, NY, United States of America

  ⨯